Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Regulus Therapeutics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +3 vs. Q3 2022
- Shares held
- 8.12M
- +2.59K (0.0%) vs. Q3 2022
- Total value
- $11.1M
- −$2.67M (−19.4%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 1
- 7 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $760 |
| Q1 2025 | 75 | $107.0M |
| Q4 2024 | 69 | $84.5M |
| Q3 2024 | 70 | $89.1M |
| Q2 2024 | 63 | $109.5M |
| Q1 2024 | 45 | $147.3M |
| Q4 2023 | 26 | $14.2M |
| Q3 2023 | 25 | $15.0M |
| Q2 2023 | 26 | $15.0M |
| Q1 2023 | 27 | $6.82M |
| Q4 2022 | 28 | $11.1M |
| Q3 2022 | 25 | $13.8M |
| Q2 2022 | 28 | $12.6M |
| Q1 2022 | 37 | $18.1M |
| Q4 2021 | 38 | $9.54M |
| Q3 2021 | 42 | $15.9M |
| Q2 2021 | 45 | $18.7M |
| Q1 2021 | 44 | $42.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 466 | $0 | 0.00% | −7,583−94.2% | Reduced |
| Royal Bank of Canada | 376 | $0 | 0.00% | −347−48.0% | Reduced |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 301 | $0 | 0.00% | +301 | New |
| Morgan Stanley | 15 | $21 | 0.00% | +15 | New |
| Bank of America Corp | 18 | $24 | 0.00% | +18 | New |
| Wells Fargo & Company | 92 | $126 | 0.00% | +2+2.2% | Added |
| Community Bank, N.A. | 690 | $938 | 0.00% | 00.0% | Unchanged |
| Endurance Wealth Management, Inc. | 675 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,662 | $7.76K | 0.00% | −4,514−44.4% | Reduced |
| Tower Research Capital LLC (TRC) | 7,002 | $10.0K | 0.00% | +6,660+1,947.4% | Added |
| Group One Trading, L.P. | 7,315 | $10.0K | 0.00% | −81−1.1% | Reduced |
| Commonwealth Equity Services, LLC | 17,500 | $23.0K | 0.00% | −16,000−47.8% | Reduced |
| Northern Trust Corp | 17,978 | $24.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 31,618 | $43.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 34,800 | $48.0K | 0.00% | +2,400+7.4% | Added |
| State Street Corp | 41,719 | $57.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 42,505 | $58.2K | 0.00% | +42,505 | New |
| BlackRock Inc. | 44,689 | $61.2K | 0.00% | −925−2.0% | Reduced |
| Geode Capital Management, LLC | 74,573 | $102.0K | 0.00% | +2,716+3.8% | Added |
| Sarissa Capital Management LP | 185,183 | $253.7K | 0.03% | 00.0% | Unchanged |
| Victory Capital Management Inc | 221,506 | $303.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 282,660 | $387.2K | 0.00% | +160+0.1% | Added |
| DAFNA Capital Management LLC | 555,555 | $761.1K | 0.21% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,445,114 | $1.98M | 0.11% | −10.0% | Reduced |
| FMR LLC | 2,195,000 | $3.01M | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,904,826 | $3.98M | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −22,735−100.0% | Sold out |